Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 25, 2018JAMA Network OpenOpen Access

New permanent pacemaker implantation after transcatheter aortic valve replacement was associated with significantly greater morbidity and mortality at long-term follow-up, but no difference in cumulative health care costs after hospital discharge.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does new permanent pacemaker implantation after transcatheter aortic valve replacement affect morbidity, mortality, and health care costs?

Population

Patients undergoing transcatheter aortic valve replacement

Comparison

New permanent pacemaker implantation vs No new permanent pacemaker implantation

Design

Cohort

Follow-up

long-term

Authors

TATalal AljabbaryFQFeng QiuSMShannon Masih

Discussion

Loading...

Member takes

Overview

May inform post-TAVR monitoring; leaves open whether new PPM drives outcomes or marks higher-risk patients.

Structured PICO

Does new permanent pacemaker implantation after transcatheter aortic valve replacement affect morbidity, mortality, and health care costs?

P
Population
Patients undergoing transcatheter aortic valve replacement
I
Intervention
New permanent pacemaker implantation
C
Comparator
No new permanent pacemaker implantation
O
Outcome
Morbidity, mortality, and cumulative health care costshard clinical

New permanent pacemaker implantation after TAVR is associated with increased long-term morbidity and mortality, though without a significant difference in post-discharge cumulative healthcare costs.

Cite This Study

Aljabbary et al. (2018) studied this question.

synapsesocial.com/papers/69d572e375589c71d767e8d1https://doi.org/10.1001/jamanetworkopen.2018.0088
View Full Paper
Ask AI
Bookmark
Share